September 2025 - Page 10 of 28

FridaySep 19, 2025 1:26 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Eyes Clear Development Pathway for AVERSA(TM) Technology

Nutriband (NASDAQ: NTRB) is a transdermal pharmaceutical developer that has secured crucial FDA engagement for its lead abuse-deterrent technology. “Nutriband’s FDA Type C Meeting approval for AVERSA(TM) Fentanyl signals agency recognition of the product’s potential to address critical unmet medical needs. The Sept. 18 meeting with the Division of Anesthesiology, Addiction Medicine, and Pain Medicine focuses on Chemistry, Manufacturing, and Controls (‘CMC’) plans spanning the entire development and commercialization timeline,” reads a recent article. “This milestone addresses the complete development arc from IND submission through 505(b)(2) NDA approval. The 505(b)(2) pathway allows Nutriband to leverage existing fentanyl safety data while focusing…

FridaySep 19, 2025 12:02 pm

QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Poised as AI and Electrification Reshape Copper Markets

Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is positioned for opportunity as AI data centers are projected to consume more than 4 million tonnes of copper by 2035, intensifying global demand. “Through Ambler Metals LLC, its 50/50 joint venture with South32, Trilogy controls the Upper Kobuk Mineral Projects in Alaska’s Ambler Mining District. The district hosts volcanogenic massive sulphide (‘VMS’) and carbonate replacement deposits containing copper, zinc, lead, gold, silver, and cobalt,” reads a recent article. “AI-driven data centers, combined with renewable energy and electrification, are reshaping copper’s demand profile. With a 50% stake in one of North America’s most prospective…

FridaySep 19, 2025 11:30 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI

Brera Holdings (NASDAQ: BREA), which is rebranding as Solmate and pivoting to a Solana-based digital asset treasury and crypto infrastructure, surged after Cathie Wood’s ARK Invest purchased 6,500,001 shares valued at about $49.72 million on Sept. 18 through ARKK, ARKW and ARKF funds. The move follows Brera’s $300 million oversubscribed private placement backed by Pulsar Group, RockawayX and ARK. Meanwhile, ARK sold 47,474 Roku (NASDAQ: ROKU) shares for roughly $4.67 million and trimmed 43,157 Tempus AI (TEM) shares for $3.73 million, while adding positions in Arcturus Therapeutics (NASDAQ: ARCT), ATAI Life Sciences (NASDAQ: ATAI), AeroVironment (NASDAQ: AVAV), Baidu (NASDAQ: BIDU)…

FridaySep 19, 2025 11:15 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Poised to Gain from Alaska Land, Road Policy Shifts

H.J. Res. 106 is designed to overturn the Central Yukon Resource Management Plan (“RMP”), a plan that has locked up 13 million acres of public land in Alaska The Ambler Access Project is a proposed 211-mile, industrial-use-only road that would connect Trilogy Metals’ Upper Kobuk Mineral Projects to the Dalton Highway These key policy moves to reverse land restrictions and advance the Ambler Road permit mark major inflection points for Trilogy Metals A wave of policy changes at the federal level has delivered two major developments that could unlock value for Trilogy Metals (NYSE American: TMQ) (TSX: TMQ). First, the…

FridaySep 19, 2025 11:10 am

QualityStocksNewsBreaks – XTI Aerospace, Inc. (NASDAQ: XTIA) Supports FAA eVTOL Integration Program, Advances TriFan 600 Toward 2027 Demonstrator

XTI Aerospace (NASDAQ: XTIA) voiced support for the FAA’s new Electric Vertical Takeoff and Landing Integration Pilot Program (eIPP), a national initiative to accelerate certification, testing and airspace access for powered-lift aircraft. CEO Scott Pomeroy said the program signals U.S. commitment to vertical flight as XTI advances its TriFan 600, designed to combine helipad and short-runway operation with fixed-wing business jet performance. XTI has flown its Sparrow and Kestrel prototypes, is preparing its TriHawk prototype, and targets a full-scale TriFan 600 demonstrator for 2027. To view the full press release, visit https://ibn.fm/FE7e6 About XTI Aerospace, Inc. XTI Aerospace (XTIAerospace.com) (Nasdaq:…

FridaySep 19, 2025 11:00 am

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Targets REE Bottlenecks with Scalable Solution

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as the Trump administration is developing a comprehensive strategy to strengthen the nation’s critical minerals production and reduce Chinese market control through guaranteed minimum pricing for domestic rare earth producers. The company “stands uniquely positioned to capitalize on this initiative through its revolutionary RapidSX(TM) technology, which addresses critical bottlenecks in rare earth element separation and processing. A recent article discussing this reads, “The company’s flagship RapidSX technology represents a breakthrough in rare earth element separation, offering significant advantages over conventional processing methods. The RapidSX technology platform has been demonstrated to process…

FridaySep 19, 2025 11:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Leveraging Positive Clinical Data to Shape Pivotal SGX942 Trial

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with unmet medical need. The company’s SGX942 is a novel therapeutic aimed at alleviating oral mucositis, a debilitating side effect of cancer therapy with no FDA-approved treatment. “Severe oral mucositis (‘SOM’) often necessitates hospitalization, opioid pain management and feeding tube placement, lowering quality of life substantially. Because of these risks, effective treatment or prevention is critical to ensuring cancer therapies remain on schedule and patients maintain nutrition and comfort,” reads a recent article. In response, the company is advancing a promising candidate,…

FridaySep 19, 2025 10:30 am

Oncotelic Therapeutics Inc. (OTLC): Leadership and Innovation Drive Late-Stage Biotech Momentum

CEO Dr. Vuong Trieu recognized as inventor of multibillion-dollar oncology assets, including Abraxane(R) and Cynviloq(TM) OTLC advancing late-stage pipeline led by OT-101 in Phase 3 for pancreatic cancer and multiple other high-unmet-need indications Recent progress includes 2 years of steady clinical and regulatory advancements across oncology and rare pediatric programs The biotechnology sector is defined by its ability to pair scientific innovation with leadership that can translate discoveries into approved therapies. This is particularly critical in oncology, where late-stage candidates must navigate complex regulatory pathways and demonstrate real clinical impact in indications with limited treatment options. Companies that combine robust…

FridaySep 19, 2025 9:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Closes $375,000 Private Placement

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based products for more accurate breast cancer screening, diagnosis and treatment, announced it has closed a non-brokered private placement of 1.5 million units at $0.25 per unit for gross proceeds of $375,000. Each unit includes one common share and one transferable warrant exercisable at $0.50 for three years. Proceeds will be used for general working capital. An insider acquired 100,000 units under exemptions from MI 61-101 requirements, and the company paid $3,500 and issued 14,000 broker warrants exercisable at $0.25 for three years in connection with the offering.…

FridaySep 19, 2025 9:45 am

Massimo Group Inc. (NASDAQ: MAMO): How Strategic Expansion Is Redefining Distribution

Massimo's recent expansion into Oregon and Arkansas adds over 100 big-box retail locations, positioning the company for significant holiday season growth through enhanced market penetration The company's Vietnam manufacturing partnership delivers supply chain diversification and cost efficiency while maintaining quality control for its feature-rich six-seater golf carts Strategic global sourcing improvements have reduced lead times and increased operational flexibility, enabling Massimo to scale effectively during peak Q3 and Q4 demand cycles Models that relied on single-source manufacturing and regional distribution are giving way to strategies that emphasize flexibility, diversification, and rapid market penetration. BRP Inc., for example, has expanded production…

Site Search

Company Search

Month: September 2025